|Year : 2021 | Volume
| Issue : 1 | Page : 42-52
Development and evaluation of injectable hydrogel as a controlled drug delivery system for metformin
Santosh S Bhujbal, Ravi V Badhe, Shradha B Darade, Siddharth S Dharmadhikari, Suresh K Choudhary
Department of Pharmaceutical Quality Assurance, Dr. D. Y. Patil Institute of Pharmaceutical Sciences and Research, Pune, Maharashtra, India
|Date of Submission||30-Dec-2019|
|Date of Acceptance||19-Jul-2020|
|Date of Web Publication||31-May-2021|
Dr. Santosh S Bhujbal
Dr. D. Y. Patil Institute of Pharmaceutical Sciences and Research, Sant. Tukaram Nagar Pimpri, Pune 411018, Maharashtra.
Source of Support: None, Conflict of Interest: None
Aim: Chitosan-dialdehyde cellulose/DAC-based injectable hydrogel for controlled release of Metformin. Materials and Methods: Biomaterial-based injectable hydrogel was prepared by incorporating chitosan and dialdehyde cellulose. Dialdehyde cellulose (A cross-linker) was prepared by periodate oxidation method. The antidiabetic agent metformin was easily mixed with the chitosan and dialdehyde cellulose cross-linked solution, for the controlled drug delivery applications. The prepared injectable hydrogel showed the shear thinning property. Results: IR spectra confirmed the presence of cross-linked network between chitosan and dialdehyde cellulose. The physical appearance, injectability, pH, sol–gel phase transition, drug content, DSC, FTIR, and SEM studies were investigated. DSC and SEM studies revealed the degradation pattern and the topographical nature of prepared injectable hydrogel, respectively. The %drug release of metformin was found to be 87.25% prolonged for 84 h. The drug release pattern revealed the effective controlled drug delivery of metformin as compared to marketed tablet formulation. Conclusion: The study suggested that the controlled drug delivery system can be incorporated into the injectable hydrogel system; it would be more potential as compared to conventional controlled drug delivery system and preformed hydrogel system.
Keywords: Controlled drug delivery, FTIR, injectable hydrogel, metformin, shear-thinning property
|How to cite this article:|
Bhujbal SS, Badhe RV, Darade SB, Dharmadhikari SS, Choudhary SK. Development and evaluation of injectable hydrogel as a controlled drug delivery system for metformin. J Rep Pharma Sci 2021;10:42-52
|How to cite this URL:|
Bhujbal SS, Badhe RV, Darade SB, Dharmadhikari SS, Choudhary SK. Development and evaluation of injectable hydrogel as a controlled drug delivery system for metformin. J Rep Pharma Sci [serial online] 2021 [cited 2021 Dec 8];10:42-52. Available from: https://www.jrpsjournal.com/text.asp?2021/10/1/42/317262
| Introduction|| |
Controlled drug release coatings have been around for more than 50 years and their performance has increased significantly since the beginning. The main limitations of conventional controlled drug delivery system are its decreased systemic availability, poor in vitro, in vivo co-relation, poor bioavailability, high-dose requirements, possibility of dose dumping, adverse side effects, low therapeutic indices, development of multiple drug resistance, and nonspecific targeting., To overcome this limitation, researcher focused on injectable hydrogel system. These is the emerging trend in the field of biomaterial drug delivery system. They overcome the limitation of preformed hydrogel, as they are injected with minimum invasive procedure into target sites and used for irregularly shaped sites. They have biocompatibility with the living tissue, that is, they have flexibility similar to natural tissue., The recent studies of injectable hydrogel for the drug delivery applications suggested that shear thinning injectable hydrogel is capable of entrapping and systematically delivering the therapeutic agents like Metformin.,, The article mainly emphasizes the shear-thinning property of Injectable hydrogel. In particular, in situ forming injectable hydrogel, the shear-thinning property of the gel plays an important role; it is the state of art that the clear free-flowing polymer sol transforms into viscoelastic gel upon exposure to the stimuli such as pH and temperature [Figure 1]. Injectable hydrogels have received much attention and they have expected to be a promising biomaterial for controlled drug delivery system and various biomedical applications., Herein, we report a biomaterial-based injectable hydrogel derived from two natural polymers such as chitosan and dialdehyde cellulose with the incorporation of metformin for controlled drug delivery applications in diabetic patients.
| Materials and Methods|| |
Chitosan (cell culture tested-high–molecular-weight grade) was obtained from Himedia, Mumbai; hydroxyethyl cellulose and sodium metaperiodate were obtained from Loba chemicals. Metformin tablets were purchased from medical store Pimpri. All other chemicals used were of analytical grade and highest purity.
Methods: preparation of chitosan-dialdehyde cellulose injectable hydrogel
Preparation of dialdehyde cellulose/DAC
Procedure: Hydroxyethyl cellulose, 10g, and sodium metaperiodate 6.6g were added in 500 mL of deionized water. The mixture was further catalyzed by using sodium chloride; 1.4g aluminum foil was wrapped carefully around periodates mixture to prevent oxidation. The mixtures were mechanically stirred gently at 20°C in the dark for desired reaction times at 1200 rpm. The excess of periodate was decomposed with distilled water; the products (DAC) were recovered and washed by centrifugation, and air-dried. The prepared dialdehyde cellulose was confirmed by IR spectra. Dried DAC was kept in water at 4°C for further use.,,,
Preparation of injectable hydrogel
The five different batches were prepared with the different concentration range of chitosan, dialdehyde cellulose, and metformin [Table 1]A. The final batch of hydrogel was optimized by considering the cross-linking between dialdehyde cellulose and chitosan [Table 1]B. The cross-linking between the DAC and chitosan was confirmed by IR spectra. The cross-linking revealed the controlled drug release pattern.
|Table 1: (A) Formulae for the chitosan-dialdehyde cellulose-based hydrogel|
Click here to view
Characterization of metformin
The characterizations of the drugs were carried out by conducting various physicochemical tests, including description, melting point determination, and spectral analysis, such as UV spectrum and IR spectrum.,
Characterizations of prepared injectable hydrogel formulation
Injectability of hydrogel
Tested by injecting hydrogel through gauge needle no. 26. This needle is widely used in the biomedical injection at subcutaneous injection site.,,
Rheology studies: viscosity
Procedure: The spindle was mounted on the viscometer. For the viscosity measurement, turn the motor switch “ON,” this energies the viscometer drive motor. Allow time for the indicated reading to stabilize. The sample was fit in sample holder and viscosity was measured by calculating % torque. The gel viscosity was measured at two points, first; gel viscosity before injecting from needle and second; viscosity after injecting from needle.
Drug content studies
Procedure: For the assay, 1g of prepared hydrogel was mixed with the 20 mL of phosphate buffer pH 7.4 for 30 min. Mixture was further filtered through membrane filter having pore size 0.45 µm. The absorbance of sample was determined spectrophotometrically at 232 nm. The dilution was done with phosphate buffer of pH 7.4. Concentration of drug was estimated from calibration curve,
Drug entrapment efficiency
Procedure: The drug-loaded 5g of prepared hydrogel was incubated in 50 mL of methanolic phosphate buffer (pH 7.4) at 25°C for 1 h. Centrifugation was carried for 10 min. The amount of free drug (metformin) was determined spectrophotometrically by collecting clear supernatant at 232 nm. The supernatant from empty hydrogel was taken as a blank.
Sol–gel phase transition
Procedure: The inverting tube method was employed for the determination of sol–gel behavior of the hydrogel. This behavior was extremely important in case of the in situ gelling system. The prepared hydrogel solution at 4°C was heated at various temperatures ranging from 0.5°C to 37°C in water bath. The gelling temperature is the temperature at which no flow being observed within 1 min by inverting the glass tubes.,
Differential scanning calorimetric
Determination of differential scanning calorimetry of hydrogel formulation
The samples were heated from 400°C to 2200°C at the rate of 100°C/min. The nitrogen gas was used as a purging gas to maintain the inert atmosphere throughout the experiment at the rate of 40 mL/min. The 1–4 mg of samples were carefully transferred and heated in a crimped aluminum pan for accurate results.
Scanning electron microscopy/SEM
Procedure: The surface topography and morphology of the hydrogel was examined using a scanning electron microscope (FEI ESEM quanta 200 analyzer). Samples were coated with gold film under vacuum using a sputter coater (SPI Sputter TM Coating Unit, SPI Supplier, Division of Structure Probe, Pennsylvania), then investigated at 200–1000 nm.,
Procedure: Swelling degrees/SDs of hydrogel was measured at 37°C. The lyophilized hydrogel was preweighed and added in excess of phosphate buffer pH 7.4. At various time intervals, the swollen hydrogel was removed using spatula and place on filter paper to remove the excess of water and reweighed. The procedure was repeated and continues until no weight increase was observed for at least 3 measured.,
The swelling degrees (Q) was calculated as follows:
where Ms is the mass in swollen state and
Md is the mass in dried state.
In vitro drug release study
Diffusion study for metformin in hydrogel formulation
Procedure: The in vitro diffusion study of the prepared hydrogel was carried out in Franz-Diffusion Cell. The Phosphate buffer (pH 7.4) at 37±1ºC was used as diffusion media. The acceptor compartment of the cell was filled with the 25 mL phosphate buffer (pH 7.4). The donor compartment was filled with the hydrogel (equivalent to 50 mg of metformin). The semi-permeable membrane (S50) was used for the permeation of the hydrogel into the acceptor compartment. At predetermined intervals, 1 mL samples were withdrawn and replaced with an equal amount of fresh buffer (pH 7.4).,
In vitro dissolution study
Metformin marketed tablet formulation (metformin tablets 500 mg bp)
Procedure: The in vitro dissolution was carried out using tablet dissolution test apparatus (VEEGO) USP type II. The dissolution medium consists of 900 mL of distilled water maintained at 37ºC±0.5°C. The drug release at different time interval was measured using an UV–visible spectrophotometer. The test sample was introduced inside the dissolution jar. The medium is allowed to attain the set position and medium is stirred at 100 rpm; 1 mL of samples were withdrawn at various time intervals such as 30 min, 1 h, 2 h.…up to 40 h. Simultaneously the sink condition was maintained. The sample withdrawn is diluted by 10 mL and absorbance is measured at 233 nm. The percentage release was calculated by using the calibration curve equation.,
| Results|| |
Characterization of metformin (standard)
The metformin from tablet formulation was found to be white powder with characteristic odor.
The melting point of metformin was determined by the programmable melting point apparatus and the melting point was found to be 216–220°C.
Preparation of standard curve (calibration curve) of metformin
Metformin obeys beers-lamberts law over this range of 2–10 µg/mL. The absorbance was measured at 232 nm in distilled water.
Assay of metformin
The percentage purity of the metformin in the formulation was found to be 99.96% (STD–100% ± 5% IP)
IR spectrum interpretation
Metformin [Figure 2]: The IR spectra interpretations of metformin are described in [Table 2].
Chitosan [Figure 3]: The IR spectra interpretations of chitosan are described in [Table 3].
Dialdehyde cellulose [Figure 4]:
The IR frequency at 1725 cm suggested the conversion of cellulose to dialdehyde cellulose.
Sodium tripolyphosphate [Figure 5]: The IR spectra interpretations of sodium tripolyphosphate are described in [Table 4].
Chitosan-dialdehyde cellulose hydrogel [Figure 6]: The IR spectra interpretations of chitosan-dialdehyde cellulose hydrogel are described in [Table 5].
|Table 5: IR absorptions of functional groups of chitosan-dialdehyde cellulose injectable hydrogel|
Click here to view
Characterization of prepared injectable hydrogel formulation
The blank hydrogel (chitosan) appeared as a slight translucent gel and dialdehyde cellulose-based hydrogel appeared as a whitish creamy colored opaque gel.
Injectability of hydrogel
The prepared hydrogel was free-flowing through 26 gauge needle.
The pH of the hydrogel was measured and it was found to be within a satisfactory limit of 6.5 to 7.5.
Rheology studies: viscosity studies
The viscosity measurements are shown in [Table 6]A and [Table 6]B].
Drug content studies
The %drug content was found to be 98.20%.
Drug entrapment efficiency
The entrapment efficiency was found to be 99.65%.
Sol–gel phase transition study
The in situ gelling temperature was found to be 37°C. The study ensures that the prepared injectable hydrogel was able to transform into the gel at the body temp after injecting into the body [Figure 7].
Differential scanning calorimetry
Differential scanning calorimetry (DSC) was performed and the result found that hydrogel formulation and TPP had melting point 102.57°C and 117.53°C, respectively, and it indicates the amorphous nature of compounds. The formulated hydrogel shows a sharp peak at 103.57◦C due to its better-organized structure. The DSC spectra of chitosan, TPP, and hydrogel formulation were summarized as follows:
Differential scanning calorimetry of chitosan [Figure 8] and [Table 7].
Differential scanning calorimetry of TPP [Figure 9] and [Table 8].
Differential scanning calorimetry of prepared hydrogel formulation [Figure 10] and [Table 9].
|Figure 10: DSC spectra of chitosan-dialdehyde cellulose hydrogel formulation|
Click here to view
Scanning electron microscopy/SEM
SEM images shows morphology of the prepared hydrogel formulation. The obtained hydrogel was irregular in particle size ranging from 20 to 300 μm, when observed at 500 xs. The image shows a more porous nature of hydrogel [Figure 11].
|Figure 11: (A–D) SEM images for the chitosan-dialdehyde cellulose hydrogel|
Click here to view
Swelling study of hydrogel
The medium water uptake ability, that is, 594.23% was assessed by determining the swelling index of Hydrogel in phosphate buffer (pH––7.4) at 37°C. The above results show that after 60 min no significant increase was observed in the swelling ability [Figure 12].
In vitro drug release studies
In vitro diffusion of metformin from hydrogel formulation
The in vitro diffusion of metformin from hydrogel formulation showed 87.28% drug release prolonged up to 84 h [Figure 13].
|Figure 13: In vitro diffusion of metformin (100 mg) from hydrogel formulation|
Click here to view
In vitro drug dissolution study
The studies were done on the marketed formulation of controlled release metformin tablet (500 mg). The results of the study were used for the comparative evaluation of drug release pattern of marketed formulation and prepared hydrogel [Figure 14].
The in vitro drug dissolution study suggested that tablet formulation containing metformin showed controlled release up to 12 h and the % drug release was found to be 99.56%.
| Discussion|| |
An injectable hydrogel was prepared from chitosan and dialdehyde cellulose with the incorporation of metformin. The percentage purity (assay) of the metformin in formulation was found to be 99.96% (STD––100% ± 5% IP). The visual inspection showed that the prepared hydrogel was opaque in nature and whitish creamy in color. The pH of formulation was found to be within a satisfactory limit of 6.5 to 7.5. The injectability study revealed that prepared hydrogel was easily passed through 26 gauge needle. Hydrogel showed maximum swelling (594.23%) in phosphate buffer of pH 7.4, the reported work also revealed the shear-thinning behavior of hydrogel. The result showed that the viscosity of hydrogel was more at the gel state but after injection in sol state it was found to be less viscous. The high drug content of hydrogel ensures the effective drug loading at the time of formulation. It also ensures the potency of drug to show the therapeutic efficacy. Entrapment efficiency was found to 99.65%. The sol–gel transition study of injectable hydrogel showed that in situ gelling temperature for injectable hydrogel was at 37°C. Differential scanning calorimetry was performed and the result found that hydrogel formulation and TPP had melting point 102.57°C and 117.53°C, respectively, and it indicates the amorphous nature of compounds. The formulated hydrogel showed a sharp peak at 103.57°C due to its better-organized structure. SEM images of hydrogel shows morphology of the resulted hydrogels. The obtained hydrogel was irregular in particle size ranging from 20 to 300 μm, when observed at 500 xs. The image shows more porous nature of hydrogel. The % drug release of Metformin from hydrogel formulation was found to be 87.25% sustained for 84 h. The drug release study suggested that the Metformin can be incorporated into the injectable hydrogel formulation for controlled drug release. The comparative drug release study of metformin hydrogel formulation with the marketed tablet formulation suggested that the metformin from hydrogel formulation herein gained high potential of controlled drug delivery for antidiabetic activity.
| Conclusion|| |
A novel cross-linked chitosan-dialdehyde cellulose blend with incorporation of drug for controlled release of metformin has been synthesized and IR spectra of the prepared hydrogel confirmed the presence of cross-linking network between incorporated components. The prepared hydrogel showed the controlled drug release pattern for metformin. The Metformin release was prolonged for 84 h and the %drug release was found to be 87.25%. Thus, the delivery of drugs through the injectable hydrogel system at the specific site herein gained the high potential regarding the targeted drug delivery system. Thus, an attempt has been made to incorporate metformin in injectable hydrogel formulation for the controlled drug delivery application would be more beneficial as compared to the conventional controlled drug delivery system and preformed hydrogel system.
Future prospective of work
Sterilization, animal studies, injectable dose optimization, and degradation study of hydrogel.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Thambi T, Li Y, Lee DS. Injectable hydrogels for sustained release of therapeutic agents. J Control Rel 2017;267:57-66.
Li J, Mooney DJ. Designing hydrogels for controlled drug delivery. Nat Rev Matter 2016;1:160-71.
Hoare TR, Kohane DS. Hydrogels in drug delivery: Progress and challenges. Polymer 2008;49:1993-2007.
Chirani N, Gritsch L, Motta FL, Fare S. History and applications of hydrogels. J Biomed Sci 2015;4:75-85.
Ganji F, Vasheghani-Farahani E. Hydrogels in controlled drug delivery systems. Iran Polym J 2009;18:63-88.
Hanafy NA, Leporatti S, El-Kemary MA. Mucoadhesive hydrogel nanoparticles as smart biomedical drug delivery system. Appl Sci 2019;9:825.
Chai Q, Jiao Y, Yu X. Hydrogels for biomedical applications: Their characteristics and the mechanisms behind them. Gels 2016;3:6.
Park KM, Park KD. Injectable hydrogels: Properties and applications. Encycl Polym Sci Technol 2016;15:1-6.
Pertici V, Pin-Barre C, Rivera C, Pellegrino C, Laurin J, Gigmes D, et al
. Degradable and injectable hydrogel for drug delivery in soft tissues. Biomacromolecules 2019;20:149-63.
Prabaharan M. Chitosan derivatives as promising materials for controlled drug delivery. J Biomater Appl 2008;23:5-36.
Lee JH. Injectable hydrogels delivering therapeutic agents for disease treatment and tissue engineering. Biomater Res 2018;22:27.
Chen MH, Wang LL, Chung JJ, Kim YH, Atluri P, Burdick JA. Methods to assess shear-thinning hydrogels for application as injectable biomaterials. ACS Biomater Sci Eng 2017;3:3146-60.
Villalba-Rodriguez AM, Dhama K, Iqbal HM. Biomaterials-based hydrogels and their drug delivery potentialities. Int J Pharmacol 2017;13:864-73.
Demitri C, Del Sole R, Scalera F, Sannino A, Vasapollo G, Maffezzoli A, et al
. Novel superabsorbent cellulose based hydrogels Crosslinked with citric acid. J Appl Polym Sci 2008;110:2453-60.
Peppas NA, Hilt JZ, Khademhosseini A, Langer. Hydrogels in biology and medicine: From molecular principles to bionanotechnology. Adv Matter 2006;18:1345-60.
Huang X, Brazel CS. On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. J Control Rel 2001;73:121-36.
Bae JW, Go DH, Park KD, Lee SJ. Thermosensitive chitosan as an injectable carrier for local drug delivery. Macromol Res 2008;14:461-5.
Patil S. Crosslinking of polysaccharides: Methods and applications. Latest Rev 2008;6:12-29.
Hu W, Wang Z, Xiao Y, Zhang S, Wang J. Advances in crosslinking strategies of biomedical hydrogels. Biomater Sci 2019;7:843-55.
Maitra J, Shukla VK. Cross-linking in hydrogels-a review. J Polym Sci 2014;4:25-31.
Saini K. Preparation method, properties and crosslinking of hydrogel: A review. Pharm Tutour 2017;5:27-36.
Almdal K, Dyre J, Hvidt S, Kramer O. What is a ‘gel’?, In macromolecular chemical. Macromol Sympt 1993;76:149-51.
Arndt KF, Schmidt T, Richter A, Kuckling D. High response smart gels: Synthesis and application. Macromol Sympt 2004;207:257-68.
Okay O. General properties of hydrogels. In: Gerlach G, Arndt KF (Eds.)Hydrogel Sensors and Actuators. Springer Series on Chemical Sensors and Biosensors;2009. Berlin, Heidelberg: Springer. p. 1-14.
Wang K, Buschle-Diller G, Misra RD. Chitosan-based injectable hydrogels for biomedical applications. Mater Technol 2015;30:198-205.
Ding J, Tracey P, Li WH, Peng GR, Whitten PG, Wallace GG. Review on shear thickening fluids and applications. Textiles Light Ind Sci Technol J 2013;2:161-73.
Barnes HA. Shear thickening (“Dilatancy”) in suspensions of non-aggregating solid particles dispersed in Newtonian liquids. J Rheol 1989;33:329-66.
Allen SD. Inventor, Body Limb Movement Limiter. United States Patent, US 7,402,147. July 22, 2008.
Samimi Gharaie S, Dabiri S, Akbari M. Smart shear-thinning hydrogels as injectable drug delivery systems. Polymer 2018;10:13-7.
Annabi N, Tamayol A, Uquillas JA, Akbari M, Bertassoni LE, Cha C, et al
anniversary article: Rational design and applications of hydrogels in regenerative medicine. Adv Mater 2014;26:85-123.
Qiu Y, Park K. Environment-sensitive hydrogels for drug delivery. Adv Drug Deliv Rev 2001;53:321-39.
Li Y, Zhang Y, Wei Y, Tao L. Preparation of chitosan-based injectable hydrogels and its application in 3D cell culture. J Vis Exp 2017;29:562-53.
Buwalda SJ, Vermonden T, Hennink WE. Hydrogels for therapeutic delivery: Current developments and future directions. Biomacromolecules 2017;18:316-30.
Guilherme MR, Garcia FP, Nakamura CV, Cardozo-Filho L, Alonso CG, et al
. Drug release profile and reduction in the in vitro burst release from pectin/HEMA hydrogel nanocomposites crosslinked with Titania. RSC Adv 2018;6: 19060-8.
[Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5], [Figure 6], [Figure 7], [Figure 8], [Figure 9], [Figure 10], [Figure 11], [Figure 12], [Figure 13], [Figure 14]
[Table 1], [Table 2], [Table 3], [Table 4], [Table 5], [Table 6], [Table 7], [Table 8], [Table 9], [Table 10], [Table 11]